antibodies Archives - Page 2 of 4

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

April 13, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, cell, Coronavirus, Coronavirus Disease COVID-19, efficacy, enzyme, Nanoparticle, Nanoparticles, pandemic, pathogen, protein, receptor, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, vaccine, virus

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases

Health News

New research could rescue failed immunotherapies for treating solid tumors

April 7, 2021 antibodies, antibody, breast cancer, cancer, cell, Immune Response, Immune System, Immunotherapy, medicine, Ovarian Cancer, protein, receptor, research, tumor

New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon

Health News

Mass vaccination needed to protect against future resurgences of COVID-19

March 19, 2021 antibodies, antibody, Blood, hospital, pandemic, respiratory, SARS, SARS-CoV-2, virus

The first long-term seroprevalence study of residents in Wuhan, China, has found that 6.9% of people in the city had

Health News

New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry

March 17, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, cell, Coronavirus, Coronavirus Disease COVID-19, enzyme, protein, Pseudovirus, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:

A brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy

Health News

Researchers show potential benefits of delaying second mRNA COVID-19 vaccine dose

March 4, 2021 antibodies, Coronavirus, Coronavirus Disease COVID-19, Mortality, protein, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, vaccine

The currently approved mRNA vaccines from Moderna and Pfizer-BioNTech help create neutralizing antibodies against the severe acute respiratory syndrome (SARS-CoV-2)

Health News

Coronavirus deranges the immune system in complex and deadly ways

March 4, 2021 antibodies, Autoantibodies, Autoimmune Disease, Bleeding, Blood, brain, chronic, Coronavirus, Education, fever, heart, Immune System, Immunology, inflammation, Influenza, liver, Lupus, medicine, muscle, pain, pandemic, Paralysis, pathogen, placebo, research, Stroke, syndrome:, vaccine, virus, Yellow Fever

There's a reason soldiers go through basic training before heading into combat: Without careful instruction, green recruits armed with powerful

Health News

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

February 16, 2021 ACE2, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, antibody, Antigen, Blood, cell, Cell Membrane, Convalescent Plasma, Coronavirus, Coronavirus Disease COVID-19, Cytometry, enzyme, Flow Cytometry, genes, genome, Genome Editing, Germline, Glycoprotein, Immune Response, Immunoglobulin, pathogen, protein, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome:, virus

The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus

Health News

Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals

February 11, 2021 ACE2, antibodies, antibody, Antigen, cell, Coronavirus, Coronavirus Disease COVID-19, medicine, protein, receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome:, vaccine

Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may

Health News

Sample Preparation for Fluorescence Microscopy

February 1, 2021 antibodies, antibody, Antigen, Biotechnology, cell, Cell Imaging, compound, Fluorescence, Fluorescence Microscopy, Fluorophore, gene, imaging, Ligand, microscopy, Primary Antibody, protein, Sample Preparation, Secondary Antibody, Tissue Culture, tumor, Wavelength

By Shelley Farrar, MSc, BSc Fluorescence Microscopy allows specimens to be studied with high sensitivity and specificity through the use

Health Problems

How to Prevent Mold Allergies

February 1, 2021 Allergic Rhinitis, allergy, antibodies, Asthma, Atopic Dermatitis, dermatitis, health care, Rhinitis

Molds are a common type of microscopic fungi that grow in warm and moist conditions, most often in the form